Anne-Marie Roguedas-Contios
Research Subjects
Anne-Marie Roguedas-Contios has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
L. Misery
Service de dermatologie, CHU de Brest, 5, avenue Foch, 29609 Brest cedex, France
2 shared publications- Alain Saraux
Université de Bretagne Occidentale (Brest University), Department of Rheumatology and PHARES Unit (Pharmacy, Research, Epidemiology, Public Health, Occupational Health), CHU Brest, INSERM LBAI (U1227), LabEx IGO, Brest, France
1 shared publication B Sassolas
1 shared publicationB. Sassolas
1 shared publication- Divi Cornec
LBAI, UMR1227, Univ Brest, Inserm, Brest, France
1 shared publication E. Crespel
1 shared publication
Latest Publications
- 1 June 2014
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 141 (6-7) , 462-463
Rémission d’un phénomène de Raynaud idiopathique après injection de toxine botulique
- 1 June 2014
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 141 (6-7) , 462-463
Rémission d’un phénomène de Raynaud idiopathique après injection de toxine botulique
- Open Access
- 17 January 2014
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 16 (1) , R15
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome
Introduction: The aims of this study were to evaluate the diagnostic accuracy of blood B-cell subset profiling and immune-system activation marker assays in primary Sjögren’s syndrome (pSS) and to assess whether adding these tools to the current laboratory item would improve the American-European Consensus Group (AECG) criteria. Methods: In a single-center cohort of patients with suspected pSS, we tested the diagnostic performance of anti-SSA, antinuclear antibody (ANA), rheumatoid factor (RF), gammaglobulins, IgG titers, and B-cell ratio defined as (Bm2 + Bm2′)/(eBm5 + Bm5), determined using flow cytometry. The reference standard was a clinical diagnosis of pSS established by a panel of experts. Results: Of 181 patients included in the study, 77 had pSS. By logistic regression analysis, only ANA ≥1:640 (sensitivity, 70.4%; specificity 83.2%) and B-cell ratio ≥5 (sensitivity, 52.1%; specificity, 83.2%) showed independent associations with pSS of similar strength. In anti-SSA-negative patients, presence of either of these two criteria had 71.0% sensitivity but only 67.3% specificity for pSS; whereas combining both criteria had 96.2% specificity but only 12.9% sensitivity. Adding either of these two criteria to the AECG criteria set increased sensitivity from 83.1% to 90.9% but decreased specificity from 97.1% to 85.6%, whereas adding both criteria in combination did not substantially modify the diagnostic performance of the criteria set. The adjunction of RF + ANA ≥1:320, as proposed in the new American College of Rheumatology (ACR) criteria, did not improve the diagnostic value of anti-SSA. Conclusions: Blood B-cell subset profiling is a simple test that has good diagnostic properties for pSS. However, adding this test, with or without ANA positivity, does not improve current classification criteria.
- 17 January 2014
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 16 (1) , R15
Open AccessDiagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome
Introduction: The aims of this study were to evaluate the diagnostic accuracy of blood B-cell subset profiling and immune-system activation marker assays in primary Sjögren’s syndrome (pSS) and to assess whether adding these tools to the current laboratory item would improve the American-European Consensus Group (AECG) criteria. Methods: In a single-center cohort of patients with suspected pSS, we tested the diagnostic performance of anti-SSA, antinuclear antibody (ANA), rheumatoid factor (RF), gammaglobulins, IgG titers, and B-cell ratio defined as (Bm2 + Bm2′)/(eBm5 + Bm5), determined using flow cytometry. The reference standard was a clinical diagnosis of pSS established by a panel of experts. Results: Of 181 patients included in the study, 77 had pSS. By logistic regression analysis, only ANA ≥1:640 (sensitivity, 70.4%; specificity 83.2%) and B-cell ratio ≥5 (sensitivity, 52.1%; specificity, 83.2%) showed independent associations with pSS of similar strength. In anti-SSA-negative patients, presence of either of these two criteria had 71.0% sensitivity but only 67.3% specificity for pSS; whereas combining both criteria had 96.2% specificity but only 12.9% sensitivity. Adding either of these two criteria to the AECG criteria set increased sensitivity from 83.1% to 90.9% but decreased specificity from 97.1% to 85.6%, whereas adding both criteria in combination did not substantially modify the diagnostic performance of the criteria set. The adjunction of RF + ANA ≥1:320, as proposed in the new American College of Rheumatology (ACR) criteria, did not improve the diagnostic value of anti-SSA. Conclusions: Blood B-cell subset profiling is a simple test that has good diagnostic properties for pSS. However, adding this test, with or without ANA positivity, does not improve current classification criteria.
- 24 May 2011
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 41 (3) , 233-236
What is Intrinsic Atopic Dermatitis?
Many authors favor a distinction between the extrinsic and intrinsic forms of atopic dermatitis. In this review, the controversy is discussed and several definitions are presented. After reviewing many papers on this topic, it is our opinion that it is useful to separate the intrinsic and extrinsic forms of atopic dermatitis or atopic eczema and atopiform dermatitis because the pathophysiology appears to be different between them. However, these terms require concrete definition and clarification of the distinction between these two concepts. This debate is a new step in the history of atopic dermatitis. It is possible that a single patient could suffer from one form and then from another but genetic differences suggest that two types could really exist.
- 24 May 2011
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 41 (3) , 233-236
What is Intrinsic Atopic Dermatitis?
Many authors favor a distinction between the extrinsic and intrinsic forms of atopic dermatitis. In this review, the controversy is discussed and several definitions are presented. After reviewing many papers on this topic, it is our opinion that it is useful to separate the intrinsic and extrinsic forms of atopic dermatitis or atopic eczema and atopiform dermatitis because the pathophysiology appears to be different between them. However, these terms require concrete definition and clarification of the distinction between these two concepts. This debate is a new step in the history of atopic dermatitis. It is possible that a single patient could suffer from one form and then from another but genetic differences suggest that two types could really exist.
- 1 March 2006
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 133 (3) , 250-252
Une pemphigoïde bulleuse épargnant un lymphœdème acquis
- 1 March 2006
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 133 (3) , 250-252
Une pemphigoïde bulleuse épargnant un lymphœdème acquis
- 30 June 2001
- Vol. 30 (22) , 1105
[Acute pancreatitis after high-dose interferon therapy in a patient with melanoma].
- 30 June 2001
- Vol. 30 (22) , 1105
[Acute pancreatitis after high-dose interferon therapy in a patient with melanoma].